The volume in Central Massachusetts ERs is still expected to grow, exacerbated by a primary care shortage and incoming $1 trillion in cuts nationally to Medicaid.
A month after seven Worcester representatives signed a letter urging UMass Chan Medical School to increase physician wages, the Worcester university has reached a tentative contract agreement with the physician union representing 700 UMass providers.
Central Massachusetts’ largest hospital, UMass Memorial Medical Center in Worcester, has named its new chief of cardiac surgery, selecting a physician from England to fill the role.
Insulet, the Acton-based medical device manufacturer and public company, has named a former global chair at multinational bank JPMorgan Chase to its board of directors.
Medical device manufacturer Hologic is going from a publicly traded company to a private business as the Marlborough-based firm is to be acquired for up to $18.3 billion.
Throughout Central Mass., healthcare organizations, nonprofit leaders, and practitioners are working to combat a startling and unsettling rise in medical misinformation and disinformation.
UMass Chan Medical School in Worcester could receive up to $18 million from the U.S. Department of Defense to lead a nationwide clinical study to determine if metformin, a drug used to treat high blood sugar and type 2 diabetes, can be used to treat a form of chronic, progressive lung disease.
Boston Scientific, a Marlborough medical device manufacturer, has entered into yet another half-billion-dollar purchase agreement, this time to acquire Nalu Medical, a California-based medical technology firm creating solutions for chronic nerve pain.
Massachusetts ranks among the top states where Medicare serves its residents the best, offering some of the best access to primary care providers, yet its beneficiaries experience the second-to-highest preventable hospital admissions rates in the nation.